For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Leeds

Return to search Previous output Next output
Output 183 of 347 in the submission
Article title

KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial

Type
D - Journal article
Title of journal
Journal of Clinical Oncology
Article number
-
Volume number
27
Issue number
35
First page of article
5931
ISSN of journal
1527-7755
Year of publication
2009
URL
-
Number of additional authors
8
Additional information
-
Interdisciplinary
-
Cross-referral requested
-
Research group
A - Cancer
Citation count
147
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-